Oncology Corporate Profile
BioMed Valley Discoveries' mission is to bring innovative treatments to patients across the world. They seek to improve human health by tackling projects that may be considered too early, too unconventional or too unprofitable for traditional biotech or pharmaceutical companies. As a member of the Stowers Group of Companies, we focus on disease-related research with a principal focus on unmet medical needs rather than commercial returns.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|BVD-523||ERK 1/2 kinase inhibitor||Acute Myelogenous Leukemia (AML)||I|
|BVD-523||ERK 1/2 kinase inhibitor||Myelodysplastic Syndrome (MDS)||I|
View additional information on product candidates here »